Latest News and Press Releases

Cambridge, UK, 17 June 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company developing antibody-based KnotBody® drugs for ion channel and G protein coupled receptor (GPCR)-driven diseases,...

Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development...

PRESS RELEASE Frits is an industry veteran with a proven track record in nephrology drug development, including the successful development of Velphoro® and Ferinject® at Vifor Pharma Schlieren /...

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Carbonated Inc. names former Puny Human CEO as its new Chief Development Officer following the closure of Puny Human in October 2023.

Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer Paul Gineste brings 25 years of experience in clinical development and strategy with leading international...

DENVER, Oct. 10, 2023 (GLOBE NEWSWIRE) -- STACK Infrastructure (“STACK”), the digital infrastructure partner to the world’s most innovative companies and a leading global developer and operator of...

VANCOUVER, British Columbia, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (NYSE American:SLI) (TSXV:SLI) (FRA:S5L), a leading near-commercial lithium...

Leadership Addition Strengthens Company's Commitment to Advancing Innovative Therapies NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the...

FORT MYERS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON), a high-growth medical oncology provider with a focus on supporting the long-term viability of...